Ajanta Pharma Reports 18.4% Rise in Q4 Net Profit on Higher US Generics Revenue
1 hour agoBusiness
27LENS
2 SourcesNew Delhi, India
TBNthebalanced.news

Ajanta Pharma Reports 18.4% Rise in Q4 Net Profit on Higher US Generics Revenue

Ajanta Pharma reported an 18.4% increase in consolidated net profit to Rs 266.7 crore for the quarter ended March 31, 2026, driven by a 56% rise in US generics revenue to Rs 505 crore. Quarterly revenue grew 21.5% to Rs 1,421.64 crore, with branded generics in India, Asia, and Africa rising 7% to Rs 859 crore. For the full fiscal year 2026, net profit increased 14.7% to Rs 1,056 crore, and revenue rose 17.3% to Rs 5,452.86 crore compared to the previous year.

Political Bias
0%100%0%
Sentiment
72%
AI analysis of 2 sources · Published under editorial oversight by The Balanced News
Analysed 5 May 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Political bias across 2 sources
● Left 0%● Center 100%● Right 0%

The articles focus on Ajanta Pharma's financial performance without political framing. Coverage centers on corporate earnings and market growth, presenting data-driven results without ideological or political commentary. Both sources emphasize business metrics and operational highlights, reflecting a neutral, economic perspective.

Sentiment — Positive (72/100)

The tone across the articles is positive, highlighting profit and revenue growth. The coverage emphasizes strong financial results and market expansion, particularly in US generics, without critical or negative language. The sentiment is optimistic regarding the company's performance and prospects.

How 2 sources covered this story

Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.

SourceTheir headlineBiasSentiment
businessstandardAjanta Pharma consolidated net profit rises 18.40 in the March 2026 quarterCenterPositive
news18Ajanta Pharma Q4 net profit rises 18.4 pc at Rs 266.7 croreCenterPositive

Coverage timeline

news18 broke this story on 5 May, 10:42 am. Other outlets followed.

  1. 1
    news185 May, 10:42 am
    Ajanta Pharma Q4 net profit rises 18.4 pc at Rs 266.7 crore
  2. 2
    businessstandard5 May, 12:02 pm
    Ajanta Pharma consolidated net profit rises 18.40 in the March 2026 quarter

Lens Score breakdown

27/100
Public interest0/100
Coverage gap100%

Well-covered story — coverage matches public importance.

Who's involved

Institutions and figures named across source coverage.

Corporate
Ajanta Pharma LtdAjanta Pharma

Story context

Category
Business
Location
New Delhi, India
Sources analysed
2
Last analysed
5 May 2026
Key entities
CroreIndian rupeeAjanta CavesGeneric drugNew DelhiAsiaAfricaIndiaPress Trust of IndiaAjanta PharmaMaricoAustralia